Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

  Pharmacist Nutriceuticals®
  USA Best®
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  Weight Loss
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Food Bars
  Branded Ingredients
  Press Releases
  Company Policy
FUTUREFOOD™ BAR [click to enlarge]

MSRP: $1.65
Internet Direct: $1.49


Mass and Strength bar
Display Box of 20 (2oz) bars with 11 grams of Protein.
The inspired great taste of FUTURE FOOD MASS & STRENGTH™ nutrition bars have made them the best tasting nutrient dense snacks available in the world!

Pharmacist References:

Vitamin A References:
1. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-73.
2. Mastroiacovo P, Mazzone T, Addis A, et al. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 1999;59:7-11.
3. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71.
4. Mejiaa LA, Chew F. Hematological effect of supplementing anemic children with vitamin A alone and a combination with iron. Am J Clin Nutr 1988;48:595-600.

Vitamin B1 References:
1. Cheraskin E, Ringsdorf WM, Medford FH, Hicks BS. The "ideal" daily vitamin B1 intake Oral Med 1978;33:77-79.

Vitamin B2 References:
1. Bhat Nutritional status of thiamine, riboflavin and pyridoxine in catarct patients. Nutr Rep Inter 1987;36:685-92.

Vitamin C References:
1. Balz F. Antioxiant vitamins and heart disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon, February 25, 1999.
2. Hemilä H. Does vitamin C alleviate the symptoms of the common cold? A review of current evidence Scand J Infect Dis 1994;26:1-6
3. Taddei S, Virdis A, Ghaidoni L, et al. Vitamin C improves endotheoium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-29
4. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
5. Taylor A. Cataract: relationship between nutrition and sxidation. J Am Coll Nutr 1993;12:138-46 [review].
6. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 1991;10:751-59.
7. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53:352S-55S
8. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
9. Robertson JM, Donner AP, Trevithick JR. vitamin E intake and risk of cataracts in humans Ann Nrl Acad Sci 1989;570:372-82.
10. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health 1994;84:788-792.
11. Vincent TE, mendiratta S, may JM. Inhibition of aldose reductase in human erythrocytes by vitamin C. diabetes Res Clin Pract1 999;43:1-8.
12. Simon JA. Ascorbic acid and cholesterol gallstones. Med Hypotheses 1993;40:81-84.
13. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers evidence for a recommended dietary allowance. Proc Natl Acad Sci USA
14. Sandstead HH. Copper bioavailability and requirements. Am J clin Nutr 1982;35:809-14 [review].
15. Finley EB, Cerklewski FL. Influence of ascorbic acid supplementation on copper status in yound adult men. Am J Clin Nutr 1983;37:553-56.
16. Piesse JW. Nutritional factors in calcium containing kidney stones wiht particular emphasis on vitamin C. Int Clin Nutr Rev 1985;5(3):110-129 [review]
17. Ringsdorf WM, Cheraskin WM. Medical complications from ascorbic acid: review and interpretation (part one). J Holistic Med 1984;6(1):49-63.
18. Hoffer A. Ascorbic acid and kidney stones. Can Med Assoc J 1985;32:320 [letter]
19. Wandzilak TR, D'Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxal levels. J Urol 1994;151:834-37.
20. Levine M. Vitamin C and optimal health. Presented at the February 25, 1999 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon.
21. Levine M, Conry-Cantilena C, wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers:evidnece for a recommended dietary allowance. proc Natl Acad Sci USA
22. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.

Calcium References:
1. Osborne CG, McTyre RB, Dudek J, et al. Evidence for the relationship of calcium to blood pressure Nutr Rev 1996;54:365-81.
2. Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patrients with ileal disease and with renal and absorptive hypercalciurias: effect of calcium and magnesium. Am J Med 1978;64:579-85.
3. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-83.
4. Bell L, Hastenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441-44.
5. Sheihk MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
6. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221-32 [review].
7. Nicar MJ, Pak CYC. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metabo 1985;61:391-93.
8. Harvey JA, Kenny P, Poindexter J, pak CYC. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. J Am Coll Nutr 1990;9:583-87.
9. Sheikh MS, Santa Ana CA, Nicar MJ, et at. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
10. Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary billiary cirrhosis. Am J Clin Nutr 1982;36:426-30.
11. Heaney RP, Recker RR, Weaver CM. Absorbability of calcium sources: the limited role of solubitt Calcif Tissue Int 1990;46:300-4.
12. Deroisy R, Zartarian M, Meurmans L, et al. Acute changes in serum calcium and parathyroid hormaone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 1997;16:249-53.
13. Burros M. Testing calcium supplements for lead. New York Times June 4, 1997,B7.
14. Bourgoin BP, Evans DR, Cornett JR, et al. Lead content in 70 brands of dietary calcium supplements. Am J Publ Health 1993;83:1155-60.
15. Civitelli R, Villareal DT, Agnusdei D, et al. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992;8:400-5.
16. Flodin NW. The metabolic roles; pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7-21 [rview].

Iron References:
1. Sullivan JL. Stored iron and ischemic heart disease. Circulation 1992;86:1036 [editorial].
2. Cutter P. Deferoxamine therapy in high-ferritin diabetes. Diabetes 1989;38:1207-10.
3. Stevens RG, Graubard BI, Micozzi MS, et al. Moderate elevation of body iron level and increased of cancer occurrence and death. Int J Cancer 1994;56:364-69.
4. Weinberg ED. Iron withholding a defense against infection and neoplasia. Am J Physiol 1984;64:65-102.
5. Oh VMS. Iron dextra and systemc lupus erthematosus. Br Med J 1992;305:1000 [letter].
6. Dabbagh AJ, Trenam CW, Morris CJ, Blake R. Iron in joint inflammation. Ann Rheum Dis 1993;52:67-73.
7. Salonen JU, Nyyssonen K, Korpela H, et al. High stored iron levels associated with excess risk of myocardial infarction in western Finnish men. Circulation 1992;86:8031-11.
8. Kechi S, Willett J, Egger G, et al. Body iron stores and the risk of carolid atherosclerosis. Circlution 1997;96:3300-3307.
9. Tzonou A, Lagiou P, Trichopoulou A, Tsousos V, Trichopoulos D. Dietary iron and coronary heart disease risk: a study from Greece. Am J Epidemiol 1998;147:161-66.
10. Danesh J, Appleby p. Coronary heart disease and iron status. Meta-analyses of prospective studies Circulation 1999;99:852-54.
11. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low stores. Am J Clin Nutr 1994;59:1381-85.
12. Suharno D, West CE, Muhilai, et al. Supplementation with vitamin A and iron for nutritional anemi, in pregnant women in West Java, Indonesia. Lancet 1993;342:1325-28.
13. Semba RD, Muhlai, West KR, Jr, et al. Impact of vitamin A supplementation on hematological indicators of iron metabolism and protein status in children. Nutr Res
14. Harness JAL, Blake DR. Penicllamine nephropathy and iron. Lancet 1982;ii:1368-69.

  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.